MiMedx Group, Inc.
NASDAQ:MDXG
9.1 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | MiMedx Group, Inc. |
Symbool | MDXG |
Munteenheid | USD |
Prijs | 9.1 |
Beurswaarde | 1,337,208,600 |
Dividendpercentage | 0% |
52-weken bereik | 5.47 - 10.14 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joseph H. Capper |
Website | https://www.mimedx.com |
An error occurred while fetching data.
Over MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)